<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0017185" disease_type="Neoplastic Process" abbrv="">Gastrointestinal tumors</z:e> are highly ranked regarding tumoral mortality worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>The development and progression of gastrointestinal (GI) diseases go hand in hand with the changes of tight junctions (TJ) </plain></SENT>
<SENT sid="2" pm="."><plain>Claudins (CLDN) are the main TJ proteins, showing different expression by the different tissues, with the expressed CLDN profile being representative </plain></SENT>
<SENT sid="3" pm="."><plain>I </plain></SENT>
<SENT sid="4" pm="."><plain>We explored the changes of CLDN expression in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and related <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>CLDN2 and -3 expression in <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> was higher than in <z:mpath ids='MPATH_458'>normal</z:mpath> foveolar epithelium </plain></SENT>
<SENT sid="6" pm="."><plain><z:mp ids='MP_0009308'>Adenocarcinoma</z:mp> showed higher CLDN2 and -3 expression compared with <z:mpath ids='MPATH_458'>normal</z:mpath> and Barrett's epithelia </plain></SENT>
<SENT sid="7" pm="."><plain>The similar CLDN expression profile of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> supports their sequential development </plain></SENT>
<SENT sid="8" pm="."><plain>II </plain></SENT>
<SENT sid="9" pm="."><plain>Gastric <z:mpath ids='MPATH_167'>intestinal metaplasia</z:mpath> showed higher expression of CLDN2, -3 and -4 as compared with <z:mpath ids='MPATH_458'>normal</z:mpath> antral foveolar mucosa </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumors</z:e> of small and large bowels exhibited higher CLDN2 expression when compared with <z:mpath ids='MPATH_458'>normal</z:mpath> epithelia </plain></SENT>
<SENT sid="11" pm="."><plain>Colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath> and <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> could not be differentiated according to their CLDN profile </plain></SENT>
<SENT sid="12" pm="."><plain><z:mpath ids='MPATH_167'>Intestinal metaplasias</z:mpath> of <z:hpo ids='HP_0100580'>Barrett's esophagus</z:hpo> and stomach show similar CLDN profile to small bowel epithelium </plain></SENT>
<SENT sid="13" pm="."><plain>III </plain></SENT>
<SENT sid="14" pm="."><plain>Studies on duodenal mucosa in <z:hpo ids='HP_0002608'>celiac disease</z:hpo> in childhood demonstrated CLDN2 and -3 expression to be higher than in <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa </plain></SENT>
<SENT sid="15" pm="."><plain>The expression was significantly higher in the distal part of the duodenum samples </plain></SENT>
<SENT sid="16" pm="."><plain>This and the serious histological findings suggest that the distal duodenum is more adequate for biopsy testing </plain></SENT>
<SENT sid="17" pm="."><plain>IV </plain></SENT>
<SENT sid="18" pm="."><plain>Beside the epithelial cells, <z:e sem="disease" ids="C1334699" disease_type="Neoplastic Process" abbrv="">mesenchymal tumors</z:e> express intercellular junctional proteins </plain></SENT>
<SENT sid="19" pm="."><plain>Expression of claudins in <z:hpo ids='HP_0100723'>gastrointestinal stromal tumors</z:hpo> (<z:hpo ids='HP_0100723'>GIST</z:hpo>) and other mesenchymal <z:hpo ids='HP_0002664'>neoplasia</z:hpo> was also studied </plain></SENT>
<SENT sid="20" pm="."><plain>The CLDN profile was found to be representative to the individual <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="21" pm="."><plain><z:hpo ids='HP_0100723'>GIST</z:hpo>, <z:mp ids='MP_0003667'>angiosarcoma</z:mp>, <z:hpo ids='HP_0001028'>hemangioma</z:hpo>, <z:hpo ids='HP_0100243'>leiomyosarcoma</z:hpo> and <z:mpath ids='MPATH_425'>leiomyoma</z:mpath> showed expression of various CLDNs </plain></SENT>
<SENT sid="22" pm="."><plain>CLDN2 was detected in <z:hpo ids='HP_0000001'>all</z:hpo> entities </plain></SENT>
<SENT sid="23" pm="."><plain>CLDN1, however, was found positive in <z:hpo ids='HP_0100243'>leiomyosarcoma</z:hpo> only </plain></SENT>
<SENT sid="24" pm="."><plain><z:mpath ids='MPATH_425'>Leiomyoma</z:mpath>, on the other hand, expressed only CLDN2 </plain></SENT>
<SENT sid="25" pm="."><plain><z:hpo ids='HP_0100723'>GISTs</z:hpo> and <z:hpo ids='HP_0100243'>leiomyosarcomas</z:hpo> showed CLDN2, -3, -4, -5 and -7-expression </plain></SENT>
<SENT sid="26" pm="."><plain>The angiogenic <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> revealed CLDN2 and -5 expression </plain></SENT>
<SENT sid="27" pm="."><plain>The similar CLDN profile observable in <z:hpo ids='HP_0100723'>GIST</z:hpo> and <z:hpo ids='HP_0100243'>leiomyosarcoma</z:hpo> is suggestive of a histogenetic relationship </plain></SENT>
<SENT sid="28" pm="."><plain>Smooth muscle and vessel <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> of different dignity could also be separated from each other based on CLDN profile </plain></SENT>
</text></document>